Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)

Autor:	Yungan Tao, S.C. Bursuc, Khalil Saleh, Caroline Even, Edouard Auclin, M. Iacobs, R.G. Herrera Gomez, L. Mayache Badis, N. Baste Rotllan, F.R. Ferrand, Laura Mezquita, Odile Casiraghi, Ingrid Breuskin, Benjamin Besse, Stéphane Temam
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty business.industry Immune checkpoint inhibitors Internal medicine medicine Basal cell Hematology Head and neck business
Zdroj:	Annals of Oncology. 29:viii387
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy287.043
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::359148500f789f81c554c53455114799 https://doi.org/10.1093/annonc/mdy287.043 Zobrazit plný text záznamu